Epigenetics and Heritable Control of Gene Expression
By Rebecca Roberts,
The Scientist
| 12. 18. 2024
The epigenome regulates nearly every process in the human body. By studying epigenetics, scientists have revealed some secrets to aging, cancer, and complex diseases.
Since its discovery in the early 1940s, epigenetics has been established as a key driver of human development, health, aging, and disease, and is now a burgeoning field of research. In this article, we discover how the epigenome can affect phenotype without changing the underlying DNA sequence, the different types of epigenetic modifications, how epigenetic marks are inherited, its effects on aging and disease, and how the epigenome can be modified for therapeutic benefit.
What Is Epigenetics?
Epigenetics is the study of various heritable alterations that control gene expression without changing the DNA sequence.1 The name epigenetics comes from the Greek prefix “epi”, which means on top of, or in addition to, genetics.2 The collection of epigenetic marks in a cell or organism is known as its epigenome.
“Epigenetics is the layer of control that sits on top of the DNA sequence itself, and it's what dictates if genes turn on or not,” explained bioengineer Brian Cosgrove, who works as a principal scientist at the epigenome editing startup Tune Therapeutics. “Another way to think about...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...